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of the Choice of Moisturiser for Eczema
Treatment (COMET) feasibility randomised
controlled trial
Kingsley Powell1*, Victoria J. Wilson1, Niamh M. Redmond1,2, Daisy M. Gaunt3 and Matthew J. Ridd1
Abstract
Background: Recruiting to target in randomised controlled trials of investigational medicinal products (CTIMPs) in
primary care and paediatric populations is notoriously difficult. More evidence is needed for effective recruitment
strategies in these settings. We report on the impact of different recruitment strategies used in the Choice of
Moisturiser in Eczema Treatment (COMET) study – a feasibility trial comparing the effectiveness of four emollients
for the treatment of childhood eczema – recruiting via general practitioner (GP) surgeries.
Methods: Initially, 16 GP practices invited potentially eligible children to take part in the trial by sending an
invitation letter (self-referral pathway) or by consenting and randomising them into the study during a visit to
the practice (in-consultation referral). Measures implemented during the study to maximise accrual included signing
up six additional GP practices, increasing the upper age limit eligibility criterion from 3 to 5 years, and permitting
healthcare professionals other than doctors to confirm participant eligibility. We used descriptive statistics and
univariate linear regression models to explore associations with practice recruitment rates.
Results: A total of 197 participants were recruited, exceeding the target of 160. Of these, 107 children entered via
self-referral and 90 by in-consultation pathways. Of the recruited population, 12.6 % were aged between 3 and
5 years (the raised upper age limit). The six additional practices contributed 37.4 % (40 of 107) of participants
recruited by self-referral. Only almost one-third (18 of 56 [32.1 %]) of potential recruiting clinicians recruited one
or more participants in-consultation, which was a more problematic pathway because of data verification issues.
Three research nurses and a pharmacist from four practices recruited 48.9 % (44 of 90) of participants via this
pathway. Univariate linear regression models showed no evidence of association between the number of children
recruited via the self-referral pathway by practice and practice list size (p = 0.092) or practice deprivation decile
(p = 0.270), but practice deprivation was associated with a higher number of children recruited in-consultation
(p = 0.020) by practice.
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Conclusions: Self-referral and in-consultation recruitment yielded similar numbers, but the in-consultation pathway
was more problematic. Future trials of this type should consider the condition, normal care pathway and number
of potentially eligible children and be prepared to use multiple recruitment strategies to achieve recruitment
targets.
Trial registration: ISRCTN21828118. Registered on 1 May 2014.
EudraCT2013-003001-26. Registered on 23 Dec 2013.
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Background
Successful recruitment is paramount for high-quality
randomised controlled trials (RCTs). Failure to recruit to
target can negatively affect the reliability of the trial
results, costs and timely dissemination of the findings
for clinical practice [1]. Because recruitment into trials is
often challenging, identifying effective recruitment strat-
egies is a common primary focus for trial methodology
research because there is a lack of evidence about which
strategies are most successful [2].
It is more challenging to recruit to clinical trials of in-
vestigational medicinal products (CTIMPs) compared
with non-CTIMPs due to the potential higher risk for
participants and the additional regulatory requirements.
Recruitment problems faced by RCTs in primary care
are also well documented [3–7]. Recruiting children has
further complexities because of their vulnerable status,
where parents’ primary concern is their child’s safety,
meaning they might be more reluctant to consent to
their child participating in an RCT [8]. Previous trials
and qualitative studies in primary care suggest that good
personal relationships with practice staff, financial incen-
tives, simple recruitment criteria and referral processes,
and support from a research nurse promote successful
recruitment [5, 6, 9–17]. Paediatric trials have shown
that parents may be more likely to allow their child to
participate if the trial offers healthcare information,
new treatments, enhanced care for their child, low
burden of involvement and appeals to their altruistic
nature [18, 19]. The role of the clinician, particularly
the way in which the clinician communicates trial in-
formation, is also a key factor in recruiting children
[8], but it is often hampered by poor clinician under-
standing of RCTs and difficulties with the informed
consent process [20–22].
Two common methods of recruiting to primary care
trials are (a) inviting patients by letter (mail-out) and (b)
inviting patients seen in a consultation at the practice
(opportunistic). For RCTs on long-term conditions, a
mail-out is generally used, with opportunistic recruit-
ment alongside if appropriate. For RCTs on acute condi-
tions, the opportunistic method may be the only option.
Very few paediatric trials in primary care have reported
detailed data on these recruitment methods. Two non-
CTIMP U.K. trials recruiting children with eczema from
general practices by mail-out reported much lower
response rates than expected, one of which had esti-
mated a 50 % response rate, whereas in reality it was
only 35 % [23, 24]. Large cohort studies of acute condi-
tions (respiratory and urinary tract infections) have suc-
cessfully recruited children in primary care through
clinicians [25, 26], but the effectiveness of this recruit-
ment method has not been reported in clinical trials.
The Choice of Moisturiser in Eczema Treatment
(COMET) trial established the feasibility of a definitive
trial comparing the clinical effectiveness and cost-
effectiveness of emollients in the treatment of childhood
eczema in primary care [27]. Classed as a CTIMP, by
virtue of the nature of the intervention and the design of
the trial, participants were recruited by both mail-out
and opportunistic recruitment. In this report, our aim
was to compare the effectiveness of two recruitment
pathways and discuss additional recruitment strategies
that enabled us to successfully recruit children with
eczema into a prospective, randomised feasibility trial.
Methods
Trial design
The aims and methods of the trial have been compre-
hensively outlined in the protocol [28] and main results
papers [27]. In summary, COMET was an RCT designed
to establish the feasibility of recruiting and randomising
young children with eczema in primary care to receive
treatment with one of four commonly prescribed emol-
lients, and following them for 3 months. The aim was to
recruit 160 children aged between 1 month and 3 years
old with doctor-diagnosed eczema and absence of a
known sensitivity to the study emollients. A formal sam-
ple size was not required, owing to the feasibility nature
of the trial. A target of 160 was chosen so that a true
consent rate of 50 % (160 children participating, having
invited 320 potentially eligible children) would be esti-
mated with 95 % CI of the order 44–56 %.
Recruitment took place over a 10-month period
(between July 2014 and April 2015) within general prac-
titioner (GP) practices in the West of England.
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Participants entered the study by one of two pathways,
described below: (1) self-referral or (2) in-consultation.
Initially, 16 practices were invited to take part, recruiting
via both pathways. Six additional practices were enrolled
later, recruiting via the self-referral pathway only. Par-
ents or carers of participants gave written informed con-
sent. The study was approved by the National Research
Ethics Service (NRES) Committee South West – Central
Bristol (reference 13/SW/0297).
Recruitment pathways
Self-referral
There were two ways in which a parent could self-refer
their child: (1) responding to an invitation letter sent
from their practice or (2) by responding to posters or
flyers displayed in practice waiting rooms. For the
former, practices identified children whose electronic
medical records had an eczema Read-coded diagnosis:
atopic dermatitis not otherwise specified (NOS), eczema
NOS, infected eczema, atopic dermatitis/eczema, infant-
ile eczema, flexural eczema or allergic eczema. GPs
screened and excluded children at their discretion,
providing a reason for the exclusion from among a pre-
defined list or by choosing ‘other’ and explaining the
decision. The remaining children were sent a letter invit-
ing them to participate in the study, a participant infor-
mation sheet, a reply slip with a personalised mail-out
identification number (ID), and a pre-paid addressed
envelope. The reply slip detailed whether the child
wanted to take part in the study or the reason for declin-
ing participation. Posters and flyers were displayed in
the waiting rooms of those practices that had agreed to
participate in the trial.
Practices recorded the number of children screened;
number eligible or reason for ineligibility; sex; mail-out
ID; date of birth; and which children were included in
the mail-out. The mail-outs were staggered, with the
first eight practices sending invitations in the first
three months of the study (June to August 2014),
followed by the remaining eight practices between
September and the end of November 2014. The latter
practices also sent reminder letters three months after
the initial mail-outs to all non-responders who still met
the eligibility criteria. Responses were received directly
by the study team via post, telephone or email. The
study team contacted the child’s parent/carer to check
their eligibility. This involved four eligibility screening
questions: (1) age of child, (2) confirmation of doctor-
diagnosed eczema, (3) adult with parental responsibility
able to give consent and (4) no known sensitivity to any
of the study emollients. The study team received a
consent form from those eligible, randomised the child
and asked the relevant practice to issue the emollient
prescription.
Practices were paid NHS Service Support Costs (SSC),
defined as clinician reimbursement costs for time spent
supporting recruitment of £288.93 for the site initiation
visit, initial search and mail-out, and £281.80 for the re-
minder letter and provision of rooms for those partici-
pants who preferred to be seen at the practice rather
than at their home. Only two children opted to be seen
at their practice.
In-consultation referral
Children were also invited to take part in the study dur-
ing a GP consultation at their practice, or an ‘in-consult-
ation referral’. Also termed opportunistic, this method
involved practice staff (mainly GPs and nurses) identify-
ing eligible children in their day-to-day consultations
and inviting them to take part. A good clinical practice
(GCP)-trained GP signed the enrolment form, confirm-
ing eligibility. A GCP-trained member of staff received
consent and randomised the child, and the practice im-
mediately issued the relevant prescription. The com-
pleted trial paperwork was faxed to the study team, and
the baseline visit was arranged. Practices received SSC of
£91.78 per child randomised.
Practice ‘research level’
The recruiting practices were members of the West of
England National Institute for Health Research Clinical
Research Network (NIHR CRN), which operates a re-
search initiative scheme. The scheme provides funding
to support infrastructure within primary care organisa-
tions to enable them to become and continue to be
research-active. Practices carrying out trial procedures
can operate at three levels, with those working at higher
levels expected to support a large number of and more
complex studies: level 1 is for practices that have proven
they can deliver primary care research to a high standard
and therefore are in a position to support NIHR CRN
portfolio studies; level 2 is for experienced practices able
to deliver on multiple NIHR CRN portfolio studies and/
or studies of higher complexity; sessional funding level is
for experienced practices that can request funded re-
search time for practice staff. The practices recruited
into COMET varied in their research level, with eight
operating at level 1, eight at level 2 and six at the
sessional funding level.
Recruitment monitoring
Recruitment was monitored on a monthly basis and
compared with the recruitment target. The accrual tar-
get per month was based on the average number of par-
ticipants per month over 10 months, and then adjusted
to account for season and time point in the study. For
example, the monthly targets were less at the start of the
trial and for December because previous experience has
Powell et al. Trials  (2016) 17:550 Page 3 of 10
shown that recruitment is slower at these times. Despite
this, accrual for the first three months of the trial was 15
children, compared with a planned target of 32. Conse-
quently, additional strategies, described below, were
implemented to try to improve recruitment.
Strategies to increase recruitment
The upper age limit was increased from 3 to 5 years of
age: 3 years had originally been chosen because the
majority of children are diagnosed by this age and we
anticipated that families would be less likely to have an
established routine with a particular emollient than older
children. The requirement of doctor-diagnosed eczema
was changed to allow a diagnosis by any ‘appropriately
qualified health professional’: The protocol was written
with the assumption that the majority of children
were given their diagnosis by a doctor (usually their
GP), but practices fed back at an early stage that
nurse practitioners working in advanced roles often
independently made the diagnosis, and therefore the
eligibility criteria did not fit with the usual care path-
way in primary care.
Permitting healthcare professionals other than doctors
to confirm participant eligibility: Originally, only doctors
were allowed to sign off eligibility, due to the GCP
principle which states, ‘[T]he medical care given to, and
medical decisions made on behalf of, subjects should al-
ways be the responsibility of a qualified physician’ [29],
page 9. Because this was a low-risk study with very sim-
ple eligibility criteria, in agreement with the study spon-
sor and through discussion with the Medicines and
Healthcare products Regulatory Agency, restrictions on
who could receive consent (GCP-trained health profes-
sional) and who could confirm eligibility (GCP-trained
GP) were relaxed to allow any appropriately qualified,
GCP-trained health professional to confirm eligibility and
any appropriately qualified health professional to receive
consent, provided it was countersigned by a GCP-trained
professional. This simplified the referral process for in-
consultation referral and increased the number of practice
staff who could be involved in recruitment.
Ultimately, we signed up six more practices to re-
cruit by the self-referral pathway only, totalling 22
practices. This second wave of practices undertook a
single mail-out (no reminder letter) in February and
March 2015 which included children in the extended
age bracket (3–5 years).
Alongside these strategies, we encouraged in-
consultation recruitment in the first wave of practices by
providing regular email support; regularly sending to
practices newsletters which included a graph of recruit-
ment per practice to generate competition between prac-
tices; awarding a prize for the top recruiting clinician;
and re-visiting most (10 of 16) practices recruiting by in-
consultation to remind them of the recruitment process
and to encourage more clinician involvement.
Data analysis
We evaluated the impact of these strategies using post
hoc descriptive analysis using Excel (Microsoft, Redmond,
WA, USA) and Stata 14.1 (StataCorp, College Station, TX,
USA) software. We examined and report recruitment
rates overall, and by the two different recruitment path-
ways (self-referral and in consultation), using percentages
and summary statistics. Univariate linear regression ana-
lyses were used to determine any association between the
number of children recruited by either the in-consultation
or the self-referral referral pathway by practice (outcome)
and practice list size, deprivation ‘decile’, and the practice
‘research level’ for the in-consultation pathway outcome
only (covariate). Practice size was defined as the number
of registered patients at the practice, data which are pub-
licly available. We did not look for an association between
the self-referral pathway and the practice ‘research level’,
because there are no grounds for expecting such an
association.
Results
Recruitment rates
The Consolidated Standards of Reporting Trials (CON-
SORT) [30] diagram in Fig. 1 shows recruitment by re-
ferral pathway. A total of 197 participants were recruited
over 10 months, exceeding the original planned target of
160. Numbers of children recruited per pathway were
similar, with 107 children entering the study by self-
referral and 90 by in-consultation referral. The baseline
characteristics of the children across the two pathways
were generally similar. However, of the 14 % (28 of 197)
who withdrew from the trial, most were recruited in-
consultation (21 of 90 [23 %] versus 7 of 107 [7 %] of
self-referrals). Retention is discussed more fully in the
main feasibility paper [27].
The cumulative recruitment by referral pathway and
overall recruitment compared with recruitment target,
as well as time points at which strategies to maximise
recruitment were implemented, are shown in Fig. 2. We
requested ethical approval for these new strategies in
September 2014, when cumulative recruitment was well
below target recruitment, but we did not receive
approval until December 2014, when cumulative re-
cruitment had improved. Figure 2 clearly shows the
self-referral pathway as the more effective recruit-
ment route in the first half of the recruitment period.
The ‘dip’ seen in the recruitment by self-referral in
January/February was due to the delay in recruiting
additional practices and undertaking the mail-outs.
There is a notable increase in the cumulative recruitment
gradient for overall recruitment and recruitment by
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pathway following these strategies. Their impact is dis-
cussed in relation to the individual referral pathways.
Recruitment by self-referral
A total of 2026 children were screened for eligibility
from the 22 participating practices, and 1849 were sent
an invitation letter in the self-referral pathway. Of these,
132 patients responded positively, of whom 25 were
excluded and 107 were recruited. The main reasons for
exclusion by the GP at the screening stage are listed in
Table 1. The majority of invitees who responded to the
invitation letter but declined to take part also gave ‘my
child no longer has eczema’ as the reason (152 of 246
[61.8 %]). Non-responders from the original 16 practices,
who still met the age eligibility criteria, were sent a
reminder letter at three months after the original
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) diagram of recruitment by referral pathway. GP General practitioner, PN Practice nurse
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letter (n = 656), which yielded only a further 4 partici-
pants. Univariate linear regression models showed no
evidence of an association between the number of
children recruited by self-referral and practice list size
(p = 0.092) or practice deprivation (p = 0.270).
The six practices that were enlisted later to boost re-
cruitment yielded 37.4 % of the recruitment by self-
referral (40 of 107). Increasing the upper age limit to
5 years resulted in recruitment of 25 children aged be-
tween 3 and 5 years over 4 months, 17 by self-referral
and 8 by in-consultation referral. This accounted for
12.6 % of total recruitment.
Recruitment yield from posters and leaflets in practice
waiting rooms and word of mouth was small. Four chil-
dren entered the study through these means, two of
whom already had siblings in the study, one of whom
was sign-posted into the study by a practice nurse, and
one of whom saw a leaflet in the practice waiting room.
Recruitment by in-consultation referral
Ninety (45.7 %) of 197 children were recruited by in-
consultation referral. Univariate linear regression models
showed no evidence of an association between the num-
ber of children recruited by practice through the in-
consultation referral pathway and the practice ‘research
level’ (p = 0.116) or the practice list size (p = 0.690).
However, practices in a lower deprivation ‘decile’ (i.e.,
more deprived areas) were associated with higher num-
bers of children recruited in-consultation (p = 0.020).
Of the 56 practice staff given access to the randomisa-
tion database as requested by the practices to enable in-
consultation referral, only slightly more than one-third
(20 of 56 [35.7 %]) actually received consent (15 GPs, 1
pharmacist and 4 research nurses). Trial regulations
meant that access to the randomisation database was
gained via a personal identification number (PIN).
Administering a unique PIN to each clinician was logis-
tically challenging: PINs had to be sent in a password-
protected email, which often had to be re-issued because
of being misplaced. In addition, three incidences of
children being randomised in error occurred. One when
a clinician was familiarising themselves with the ran-
domisation system, and two children who were rando-
mised before their consent forms had been completed.
These resulted in protocol breaches and generated add-
itional work for the study team.
Relaxing regulatory restrictions to allow non-GCP-
trained health professionals to receive consent (with the
caveat that the consent form be countersigned by a per-
son who was GCP-trained) resulted in recruitment of
two participants by a non-GCP-trained clinician. The
Fig. 2 Cumulative recruitment in total and by referral pathway versus target recruitment and time points when key recruitment strategies were
implemented. GCP Good clinical practice, GP General practitioner, HP Health professional
Table 1 Reasons for general practitioner excluding children
during screening of mail-out list for self-referral pathway
Reason for exclusion Number excluded (%)
No longer has eczema 66 (37.3 %)
Not officially diagnosed 39 (22.0 %)
Parents/carers unable to complete
questionnaires
23 (13.0 %)
Adverse medical or social circumstances 19 (10.7 %)
Other 30 (16.9 %)
Total 177 (100 %)
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majority of consent was still taken by a GCP-trained
professional.
Figure 3 shows recruitment per month by the four re-
search nurses and the pharmacist. The arrow indicates
the time point at which they, instead of the GP, could
confirm eligibility. There is a sharp increase in recruit-
ment after this time point, with 12 children recruited in
the five months prior to this change in protocol com-
pared with 32 children in the latter four months. The
drop in recruitment rate between March and April, as
shown in Fig. 3, reflects the fact that two of the research
nurses were asked to cease recruitment at the end of
March because recruitment was above the original
planned target at that stage. Overall, they recruited al-
most half of the children via this pathway (44 of 90
[48.9 %]). There was minimal difference in the with-
drawal rate between those recruited by the research
nurses and the pharmacist versus those recruited by the
GPs (23.5 % versus 25 %, respectively).
Anecdotally, the study team found that this referral
pathway generated additional work. Much of this was
due to incomplete or incorrect paperwork by practice
staff, including errors in consent form completion and
missing case report form pages. Consequently, there
were multiple communications back and forth with
practices. Time was also spent visiting practices to pro-
mote more and better in-consultation recruitment (due
to slower-than-expected rates). This additional effort ap-
peared to have minimal impact because practices already
recruiting well continued to do so, and activity in prac-
tices with little or no recruitment via this pathway did
not increase their rates.
Discussion
In the COMET feasibility trial, using two recruitment
pathways and implementing additional strategies dur-
ing the course of the study resulted in participant re-
cruitment above the original planned target. Accrual
was similar between the two recruitment pathways,
with slightly fewer children recruited by in-
consultation. This is contrary to what we had ex-
pected – that patients presenting to clinicians were
more likely to be ‘emollient naive’ and therefore more
willing to take part in the study. Interestingly, recruit-
ment by this pathway was higher in practices in more
deprived areas (p = 0.020). This probably reflects the
fact that our highest recruiting clinicians were based
in those practices, but it may warrant further explor-
ation in the other studies. This pathway was more
labour-intensive for the trial staff because of poorer-
quality data collection by practice staff and a higher
number of data queries. Withdrawal rates were also
higher for the in-consultation pathway, which may
reflect insufficient time or explanation of what was
involved in taking part in the trial.
Our evaluation showed that a number of strategies
worked in combination to increase cumulative recruit-
ment. Several factors should be considered when recruit-
ing children to trials in primary care: target population,
recruiting via healthcare professionals and use of mul-
tiple recruitment strategies.
Target population
‘No longer has eczema’ was the primary reason for
exclusion at the screening stage prior to the mail-out
Fig. 3 Recruitment per month by research nurses and pharmacist and implementation of recruitment strategy. GP General practitioner,
HP Health professional
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(n = 66) and for parents declining participation (152
of 246 [61.8 %]). A large proportion of those identi-
fied for the mail-out were also excluded because they
had not been diagnosed by a healthcare professional
(n = 39). Thus, in similar populations where diagnosis
may be uncertain or transient, such as patients with
childhood asthma, it should be expected that a large
proportion of potentially eligible patients will not
have a confirmed diagnosis or will no longer have the
condition, as the Read codes in electronic medical re-
cords cannot be relied upon to exclude such patients.
Accounting for this should aid calculations of return
and recruitment rates for trials that employ this
method of recruitment. The specificity of searches for
potentially eligible participants can probably be im-
proved by adding search criteria such as evidence of
active disease through a recent relevant prescription,
as in the Bath Additives in the Treatment of Child-
hood Eczema (BATHE) study [31]. The decision re-
garding our original, narrower age range for eligibility
was made on the basis that we thought older children
were more likely to have an established treatment
regimen and therefore would be less willing to be
randomised to a different emollient. However, a re-
cruitment yield of 12.6 % for children between the
ages of 3 and 5 years (after the age criteria were
broadened) suggests that there are still many families
with older children who have not yet found a pre-
ferred emollient. Extrapolating from this result, we
speculate that it is possible that, had the upper age
limit been 5 years from the start of the study, an add-
itional 26 % (taking an average of an additional six
children per month) might have been recruited over
the full 10-month recruitment period. Despite evi-
dence derived from survey literature that reminders
are helpful in increasing response rates [32], reminder
invitation letters sent to non-responders in our trial
yielded four participants. It may be that an interim of
three months between the initial and reminder letters was
too long. Telephone reminders may have been more gen-
erative, as indicated by the results of other primary care
trials [33, 34]. The normal care pathway of the child and
regulatory restrictions are also an important consider-
ations. Many participants were seen and recruited by
nurses, but governance restrictions on who could
complete the trial paperwork hampered recruitment by
this route. When these restrictions were relaxed, there
was a rapid increase in the number of patients being re-
ferred into the trial by health professionals other than doc-
tors (Fig. 3). When designing trials, researchers should
give consideration to who normally diagnoses and treats
the condition in question. If this includes health profes-
sionals other than doctors, they should be included in the
eligibility criteria if at all possible.
Recruiting via healthcare professionals
The number of recruiting clinicians was much less than
expected, with only about one-third of clinicians able to
randomise actually referring a patient into the study.
Frank discussions with practices about the work involved
in recruiting participants should mean that only health
professionals who are able to fully commit to the study
agree to be involved. We found that recruitment by
health professionals was associated with more proced-
ural problems and incorrectly completed paperwork,
even though on-site training was provided, the clinician
reimbursement costs were generous, and the paperwork
was completed or countersigned by a GCP-trained pro-
fessional. To ensure high-quality and consistent research
processes for consent and data collection, researchers
should not make any assumptions about the competence
of GCP-trained clinicians. Ongoing support from the
trial team was essential to keeping practice staff engaged
with our trial. Continued support from the trial staff
should be factored into the trial design in terms of time
and financial support. Practice nurses at participating
practices in our trial were better at recruiting, in terms
of both recruitment yield and observing research pro-
cesses. The literature is increasingly recognising the im-
portance of the role of nurses in recruitment in primary
care [10, 14, 35]. Researchers in future trials may wish to
focus on nurses recruiting participants, depending on
the population under investigation and their routine care
pathway.
Multiple recruitment strategies
We predicted that the in-consultation referral would
work more favourably than the self-referral pathway,
but both pathways produced very similar numbers of
participants. The self-referral pathway was key in the
early stages of recruitment because it took a while for
the general practices to start recruiting by in-
consultation. Self-referral also provided a steady influx
of participants whom the study team had some con-
trol over by dictating the timing of the mail-outs,
whereas the in-consultation route was more unpre-
dictable. Therefore, we advise using a number of
recruitment strategies to spread the risk, should one
strategy prove more challenging or less fruitful than
another. This is in agreement with other trial re-
searchers who recommend using a number of strat-
egies [36, 37]. We also emphasise the importance of
careful recruitment monitoring because the additional
measures we implemented during the trial (such as
increasing the upper age limit and recruiting more
practices) had an important and positive impact on
recruitment and may not necessarily have been identi-
fied without monitoring.
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Limitations
First, there is a lack of evidence about the consistency
with which the trial information was provided to
parents/carers by clinicians versus the study team, with
anecdotal evidence suggesting that self-referral partici-
pants were better informed than in-consultation partici-
pants about the trial and its commitments. Second,
owing to poor completion of clinician screening logs, we
have very limited data on the number of children
approached in-consultation and reasons for non-
participation. This information would have been useful
for developing successful strategies. Third, we did not
collect any ‘workload’ measures per pathway, because we
did not anticipate this to be relevant, but, in hindsight,
we could have tried to quantify this. Fourth, nested
qualitative work might have helped us understand the
issues better. Fifth, although this trial was classified as a
CTIMP, it was a very low-risk trial using investigational
medicinal products that can be bought over the counter,
so some of the findings may not be applicable to higher-
risk CTIMPs. This, and future feasibility studies, may
benefit from a qualitative component to facilitate further
understanding of feasibility issues.
Conclusions
Shared learning of effective recruitment strategies is
important for supporting the design of future trials to
ensure successful recruitment, particularly for children
in primary care trials. In our study, self-referral and in-
consultation recruitment yielded similar numbers,
though there were more barriers to efficient recruitment
via the in-consultation pathway. Both pathways were
supported by recruitment strategies implemented mid-
study which worked to boost cumulative recruitment.
Researchers in future trials of this type should consider
the condition, care pathway and number of potentially
eligible children and be prepared to use multiple recruit-
ment strategies to achieve recruitment targets.
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